All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 1984-11-05? to Mon 2025-03-24 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
+13.84%
2025-03-24 |
17.58 TRR
2025-03-24 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Mon 2025-03-24 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+1,657.98%
+7.36%/yr |
+5.21%/yr
(R2=0.681) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Mon 2025-03-24 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1984-11-05 |
$175,797.63
2025-03-24 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | +13.84% |
2024 | −7.81% |
2023 | +6.15% |
2022 | −23.22% |
2021 | +18.28% |
2020 | −18.88% |
2019 | +26.25% |
2018 | +11.54% |
2017 | −5.06% |
2016 | −0.11% |
2015 | −1.07% |
2014 | −16.40% |
2013 | +26.90% |
2012 | −1.15% |
2011 | +18.93% |
2010 | −3.65% |
2009 | +16.08% |
2008 | −22.40% |
2007 | −4.75% |
2006 | +5.25% |
2005 | +6.15% |
2004 | +2.22% |
2003 | +26.30% |
2002 | −23.46% |
2001 | −11.04% |
2000 | +0.66% |
1999 | −20.08% |
1998 | +45.76% |
1997 | +53.17% |
1996 | +14.05% |
1995 | +41.50% |
1994 | +0.33% |
1993 | −12.84% |
1992 | −25.16% |
1991 | +92.98% |
1990 | +22.87% |
1989 | +32.48% |
1988 | +2.45% |
1987 | +15.33% |
1986 | +37.66% |
1985 | +68.45% |
1984 | −1.91% |
Mon 1984-11-05? to Mon 2025-03-24 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −19.29% |
−60.56%
2009-03-09 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||